NasdaqGS - Nasdaq Real Time Price USD
Bio-Techne Corporation (TECH)
50.69
+0.53
+(1.05%)
As of 12:18:19 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 10 | 12 | 13 |
| Avg. Estimate | 0.51 | 0.53 | 1.89 | 2.17 |
| Low Estimate | 0.49 | 0.48 | 1.81 | 1.95 |
| High Estimate | 0.52 | 0.56 | 1.92 | 2.4 |
| Year Ago EPS | 0.48 | 0.49 | 1.77 | 1.89 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 11 | 14 | 13 |
| Avg. Estimate | 317.33M | 325.45M | 1.23B | 1.33B |
| Low Estimate | 313.35M | 320.92M | 1.22B | 1.3B |
| High Estimate | 321.8M | 331.03M | 1.24B | 1.37B |
| Year Ago Sales | 303.43M | 306.1M | 1.16B | 1.23B |
| Sales Growth (year/est) | 4.58% | 6.32% | 6.05% | 8.36% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.46 | 0.49 | 0.38 | 0.39 |
| EPS Actual | 0.48 | 0.49 | 0.42 | 0.42 |
| Difference | 0.02 | -0 | 0.04 | 0.03 |
| Surprise % | 5.27% | -0.96% | 10.24% | 7.77% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.51 | 0.53 | 1.89 | 2.17 |
| 7 Days Ago | 0.51 | 0.54 | 1.89 | 2.19 |
| 30 Days Ago | 0.51 | 0.55 | 1.9 | 2.21 |
| 60 Days Ago | 0.51 | 0.55 | 1.9 | 2.2 |
| 90 Days Ago | 0.51 | 0.56 | 1.89 | 2.2 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 2 | 2 |
| Down Last 30 Days | 2 | 3 | 1 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TECH | 5.66% | 8.93% | 6.58% | 15.21% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Downgrade | Keybanc: Overweight to Sector Weight | 4/9/2025 |
| Downgrade | Keybanc: Overweight to Sector Weight | 4/8/2025 |
| Initiated | Evercore ISI Group: Outperform | 3/18/2025 |
| Maintains | Citigroup: Neutral to Neutral | 3/4/2025 |
| Downgrade | Baird: Outperform to Neutral | 2/19/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/6/2025 |
Related Tickers
NUVL Nuvalent, Inc.
72.29
-0.58%
GMAB Genmab A/S
20.52
+1.94%
BMRN BioMarin Pharmaceutical Inc.
62.72
+1.25%
INCY Incyte Corporation
58.41
+0.71%
PCVX Vaxcyte, Inc.
33.42
+0.77%
ROIV Roivant Sciences Ltd.
10.90
+1.44%
RPRX Royalty Pharma plc
32.04
+1.09%
JAZZ Jazz Pharmaceuticals plc
107.81
+3.48%
IMVT Immunovant, Inc.
14.75
+2.08%
ASND Ascendis Pharma A/S
157.61
-0.34%